Skip to main content
SpringerLink
Log in
Book cover

Diabetes-Therapie – informiert entscheiden pp 133–136Cite as

Fall 34: Prävention – 72 Jahre, ♂, Prädiabetes, Übergewicht, grenzgradige Nüchternglukose, normaler oraler Glukosetoleranztest

  • Chapter
  • First Online:

  • 2284 Accesses

Zusammenfassung

Ein 72-jähriger Patient mit grenzgradiger Nüchternglukose, normalem oralen Glukosetoleranztest, einem BMI von 38, einer gut eingestellten Hypertonie, nächtlichem Kribbeln seit 5 Jahren, kleinen Bulbusplaques und nicht bisher zum Infarkt führenden Koronarstenosen, fragt nach den Möglichkeiten der Diabetesprävention. Hat er nicht schon einen Diabetes „ohne Hyperglykämie“?

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   29.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Literatur

  • Callaghan BC, Xia R, Reynolds E, Banerjee M, Rothberg AE, Burant CF, Villegas-Umana E, Pop-Busui R, Feldman EL (2016) Association between metabolic syndrome components and polyneuropathy in an obese population. JAMA Neurol 73(12):1468–1476. https://doi.org/10.1001/jamaneurol.2016.3745

    Article  PubMed  PubMed Central  Google Scholar 

  • Diabetes Prevention Program Research G (2015) Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol 3(11):866–875. https://doi.org/10.1016/S2213-8587(15)00291-0

    Article  CAS  Google Scholar 

  • Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research G (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346(6):393–403. https://doi.org/10.1056/NEJMoa012512

    Article  Google Scholar 

  • Li G, Zhang P, Wang J, An Y, Gong Q, Gregg EW, Yang W, Zhang B, Shuai Y, Hong J, Engelgau MM, Li H, Roglic G, Hu Y, Bennett PH (2014) Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. Lancet Diabetes Endocrinol 2(6):474–480. https://doi.org/10.1016/S2213-8587(14)70057-9

    Article  PubMed  Google Scholar 

  • Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, Li H, Li H, Jiang Y, An Y, Shuai Y, Zhang B, Zhang J, Thompson TJ, Gerzoff RB, Roglic G, Hu Y, Bennett PH (2008) The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 371(9626):1783–1789. https://doi.org/10.1016/S0140-6736(08)60766-7

    Article  PubMed  Google Scholar 

  • Perreault L, Pan Q, Mather KJ, Watson KE, Hamman RF, Kahn SE, Diabetes Prevention Program Research G (2012) Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet 379(9833):2243–2251. https://doi.org/10.1016/S0140-6736(12)60525-X

    Article  CAS  Google Scholar 

  • Tancredi M, Rosengren A, Svensson AM, Kosiborod M, Pivodic A, Gudbjornsdottir S, Wedel H, Clements M, Dahlqvist S, Lind M (2015) Excess mortality among persons with type 2 diabetes. N Engl J Med 373(18):1720–1732. https://doi.org/10.1056/NEJMoa1504347

    Article  CAS  PubMed  Google Scholar 

  • Task Force Members: Ryden L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, Deaton C, Escaned J, Hammes HP, Huikuri H, Marre M, Marx N, Mellbin L, Ostergren J, Patrono C, Seferovic P, Uva MS, Taskinen MR, Tendera M, Tuomilehto J, Valensi P, Zamorano JL, Guidelines ESCCfP, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Document R, De Backer G, Sirnes PA, Ezquerra EA, Avogaro A, Badimon L, Baranova E, Baumgartner H, Betteridge J, Ceriello A, Fagard R, Funck-Brentano C, Gulba DC, Hasdai D, Hoes AW, Kjekshus JK, Knuuti J, Kolh P, Lev E, Mueller C, Neyses L, Nilsson PM, Perk J, Ponikowski P, Reiner Z, Sattar N, Schachinger V, Scheen A, Schirmer H, Stromberg A, Sudzhaeva S, Tamargo JL, Viigimaa M, Vlachopoulos C, Xuereb RG (2013) ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 34 (39): 3035–3087. https://doi.org/10.1093/eurheartj/eht108

  • Uusitupa M, Peltonen M, Lindstrom J, Aunola S, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Valle TT, Eriksson JG, Tuomilehto J, Finnish Diabetes Prevention Study G (2009) Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study–secondary analysis of the randomized trial. PloS one 4(5):e5656. https://doi.org/10.1371/journal.pone.0005656

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung Innere Medizin I, Medizinische Universitätsklinik, Heidelberg, Deutschland

    Stefan Kopf

Authors
  1. Stefan Kopf
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stefan Kopf .

Editor information

Editors and Affiliations

  1. Abteilung Innere Medizin I, Medizinische Universitätsklinik, Heidelberg, Germany

    Lars Kihm

  2. Abteilung Innere Medizin I, Medizinische Universitätsklinik, Heidelberg, Germany

    Stefan Kopf

  3. Zentrum für Innere Medizin I und klinische Chemie, Medizinische Universitätsklinik, Heidelberg, Germany

    Peter Nawroth

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kopf, S. (2018). Fall 34: Prävention – 72 Jahre, ♂, Prädiabetes, Übergewicht, grenzgradige Nüchternglukose, normaler oraler Glukosetoleranztest. In: Kihm, L., Kopf, S., Nawroth, P. (eds) Diabetes-Therapie – informiert entscheiden. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-55972-7_34

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-55972-7_34

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-55971-0

  • Online ISBN: 978-3-662-55972-7

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation